Shahid Akhtar Ansari

Title: Shahid Akhtar Ansari: Innovator in Pharmaceutical Chemistry

Introduction

Shahid Akhtar Ansari is a notable inventor based in Karnataka, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of important intermediates for anticonvulsant medications. His work has implications for the treatment of various neurological disorders.

Latest Patents

Shahid Akhtar Ansari holds a patent for a process titled "Process for the preparation of 10-methoxycarbamazepine." This process involves the preparation of 10-methoxycarbamazepine, which is a crucial intermediate in synthesizing oxcarbazepine. The patent outlines a method that includes reacting 10-methoxyiminostilbene with cyanic acid in the presence of a mild acidic reagent. Additionally, it describes an improved hydrolysis method for converting 10-methoxycarbamazepine to oxcarbazepine, which is proposed for use in treating AIDS-related neural disorders and Parkinson's disease.

Career Highlights

Shahid Akhtar Ansari is currently associated with Max India Limited, where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

He has collaborated with notable colleagues such as Ravindra Bhat and Ashok Krishna Kulkarni. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.

Conclusion

Shahid Akhtar Ansari's contributions to pharmaceutical chemistry, particularly through his patent on 10-methoxycarbamazepine, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also has the potential to improve treatment options for patients with neurological disorders.